Daiwa Securities Group’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23K | Buy |
77
+5
| +7% | +$1.49K | ﹤0.01% | 1095 |
|
|
2025
Q1 | $24K | Hold |
72
| – | – | ﹤0.01% | 1065 |
|
|
2024
Q4 | $22K | Sell |
72
-11
| -13% | -$3.36K | ﹤0.01% | 1084 |
|
|
2024
Q3 | $18K | Buy |
83
+9
| +12% | +$1.95K | ﹤0.01% | 1104 |
|
|
2024
Q2 | $21K | Hold |
74
| – | – | ﹤0.01% | 1126 |
|
|
2024
Q1 | $20K | Sell |
74
-7
| -9% | -$1.89K | ﹤0.01% | 1130 |
|
|
2023
Q4 | $19K | Buy |
81
+12
| +17% | +$2.82K | ﹤0.01% | 1123 |
|
|
2023
Q3 | $10K | Hold |
69
| – | – | ﹤0.01% | 1120 |
|
|
2023
Q2 | $16K | Hold |
69
| – | – | ﹤0.01% | 1108 |
|
|
2023
Q1 | $17K | Hold |
69
| – | – | ﹤0.01% | 1076 |
|
|
2022
Q4 | $20K | Buy |
69
+12
| +21% | +$3.48K | ﹤0.01% | 1077 |
|
|
2022
Q3 | $4K | Hold |
57
| – | – | ﹤0.01% | 1170 |
|
|
2022
Q2 | $4K | Hold |
57
| – | – | ﹤0.01% | 1175 |
|
|
2022
Q1 | $6K | Hold |
57
| – | – | ﹤0.01% | 1155 |
|
|
2021
Q4 | $5K | Hold |
57
| – | – | ﹤0.01% | 1192 |
|
|
2021
Q3 | $5K | Buy |
57
+28
| +97% | +$2.46K | ﹤0.01% | 1172 |
|
|
2021
Q2 | $3K | Hold |
29
| – | – | ﹤0.01% | 1107 |
|
|
2021
Q1 | $3K | Hold |
29
| – | – | ﹤0.01% | 1110 |
|
|
2020
Q4 | $3K | Buy |
+29
| New | +$3K | ﹤0.01% | 1087 |
|